sabbiotech L3042-2说明书

sabbiotech L3042-2说明书

兔抗山羊IgG二抗HRP偶联

L3042-2

货号 包装尺寸 价钱
L3042-2 1毫升 $ 85.00
  • 产品名称兔抗山羊IgG二抗HRP共轭标签
  • 简要说明二抗
  • 克隆多克隆
  • 应用WB IHC ELISA
  • 物种反应性山羊
  • 免疫原型
  • 免疫原描述使用山羊IgG作为免疫原在兔体内开发了抗血清。
  • 结合HRP
  • 目标名称山羊IgG
  • 在磷酸盐缓冲液(不含Mg2 +和Ca2 +),pH 7.4、150mM NaCl,50%甘油中配制HRP标记的兔IgG。
  • 储存-20℃/ 1年

申请详情

 

 酶联免疫吸附测定:1:5000-1:20000

蛋白质印迹:1:5000-1:10000

免疫组织化学:1:1000-5000

 

 

 

 

 

 

BIOCHECK BC-1303操作方法

BIOCHECK Inc.是新抗体发现和免疫测定开发服务的综合提供商。利用我们专有的B细胞克隆技术,我们可以直接富集阳性B细胞,分离IgG基因并表达用于各种应用的重组抗体。我们还是免疫诊断领域的开发商和制造商,在将新的IVD产品推向市场方面拥有丰富的经验。除了ELISA之外,我们现在还包括使用Simoa™技术(单分子阵列)进行超灵敏检测的分析开发,这是一种检测低丰度生物标记物的强大工具。

PD-L1 ENZYME IMMUNOASSAY TEST KIT Catalog Number: BC-1303

pd-l1酶免疫测定试剂盒目录编号:bc-1303

 

酶免疫法定量测定人血清和血浆中Pd-L1的浓度

 

只作研究用途

 

不适用于诊断程序

 

介绍

 

程序性死亡受体-配体1(pd-l1,b7-h1,cd 274)是b7家族的一种生物标志物,在多种细胞上表达,并在多种促炎细胞因子(如int)作用下被上调。 ERFERFON GAMMA 1,2,3。pd-L1与耗尽的T细胞表达的辅助受体pd-1相互作用,通过减少T细胞受体介导的增殖,促进免疫抑制性肿瘤微环境的形成。 N和细胞因子产生4,5。pd-1/pd-l1相互作用在免疫编辑过程中起着免疫检查点的作用,宿主免疫系统在此过程中消除了高免疫原性肿瘤。 使较少的免疫原性肿瘤逃避2,6。包括黑色素瘤、肾细胞癌、非小细胞肺癌、卵巢癌和结直肠癌在内的多种实体肿瘤类型利用pd-1/pd-L。 1免疫编辑机制。目前的治疗主要集中在阻断PD-1/Pd-L1相互作用,通过抑制Pd-1来减少肿瘤的逃逸,而Pd-L1和1,2则是新的研究重点。

测定原理

 

pd-L1酶联免疫吸附试验基于固相酶联免疫吸附试验的原理.该检测系统利用一种*的单克隆抗体对,针对一种*的抗原性测定方法。 Pd-L1分子上的蚂蚁。用一种小鼠抗Pd-L1单克隆抗体进行固相固定化(在微滴度井上)。另一种与马血清结合的单克隆抗pd-l1抗体 盘过氧化物酶(HRP)存在于酶的共轭溶液中。测试样本被允许与这两种抗体顺序反应,导致pd-l1分子被夹在溶胶之间。 ID期和酶解抗体。在室温下进行两次单独的60分钟孵育后,用洗涤缓冲液冲洗水井,除去未结合的标记抗体。添加TMB试剂 ED在黑暗条件下孵育20分钟,形成蓝色。随着停止解决方案的添加,颜色开发停止,将颜色更改为黄色。 Pd-L1的浓度与样品的颜色强度成正比。在450 nm处分光度法测定吸光度。

 

提供的试剂和材料

 

1.抗体包被井(1板,96井)微滴度井,用小鼠单克隆抗pd-l1包被。

 

2.20 ng/ml Pd-L1标准品(0.5 mL/小瓶)20 ng/mL Pd-L1在含防腐剂的磷酸盐缓冲液-BSA溶液中

 

3.标准稀释剂和样品稀释剂(30 mL/瓶,1瓶)含有含防腐剂的磷酸盐缓冲液-bsa溶液。

 

4.酶结合试剂(12 mL/小瓶,1小瓶)含有与辣根过氧化物酶结合的小鼠单克隆抗pd-l1。

 

20倍洗涤剂磷酸盐缓冲液(50 mL/瓶,1瓶)

 

TMB试剂(11 mL/瓶,1瓶)含有一步TMB溶液。

 

7. 停液(11 mL/瓶,1瓶)含有稀释盐酸(1NHCl)

 

 

贮藏条件

 

1.将未打开的工具包保存在2-8°C,收到后,当它没有使用,直到到期显示在工具包标签上。有关过期日期,请参阅包标签。

 

2.将微滴度板放在一个装有干燥剂的密封袋中,以尽量减少对潮湿空气的暴露。

 

试剂准备

 

1.所有试剂在使用前应允许达到室温(18-25°C)。

 

2.对于每次测试运行,准备一个新的标准集。

 

3.稀释20 ng/mL标准品至5ng/mL。用标准/样品稀释剂制备5纳克/mL标准的两倍系列稀释剂:

 

a.5 ng/mL:0.15mL 20 ng/mL标准品/样品稀释剂0.45mL

 

b.2.5纳克/毫升:0.25毫升5纳克/毫升标准品/样品稀释剂

 

c.1.25纳克/毫升:0.25毫升2.5纳克/毫升标准品/样品稀释剂

 

d.0.625 ng/mL:1.25ng/mL标准品/样品稀释剂0.25mL

 

e.0.313 ng/mL:0.25mL 0.625 ng/mL标准品/样品稀释剂

 

f.0.156 ng/mL:0.25mL 0.313 ng/mL标准稀释剂

 

g.0.078 ng/mL:0.25mL 0.156 ng/mL标准稀释剂

 

H.0 ng/mL:0.25 mL标准稀释剂

 

5.病人样本在使用前需要稀释4倍。制备一系列小管(即1.5 mL微离心管),将60L血清与180 L标准/样品稀释剂混合。

 

6. 工作洗涤缓冲器:从20倍库存中制备1倍洗涤缓冲液。加入50毫升的20倍洗涤缓冲液库存到950毫升的直接水。工作洗涤缓冲液在2~8°C温度下稳定运行30天.注:任何晶体 这可能是由于高盐浓度的存在,必须在室温下再溶解,然后再进行稀释。

检测程序

 

1.准备标准。见试剂准备。

 

2.稀释样品1:4稀释。见试剂准备。

 

3.确保所需数量的涂层井在保持架。

 

4.配发Pd-L1标准的100mL,并将样品稀释到适当的井中.

 

5.室温(18-25°C)孵育60 min.

 

6.将培养皿中的内容物倒入废容器中,将孵化器中的混合物移除。用300mL工作水洗缓冲液冲洗微滴水井5次。把井打在吸水性纸或p上 锥度毛巾,以消除所有残余水滴。

 

7.将pd-L1工作酶结合剂的100mL分配到每口井中.

 

8.室温(18-25°C)孵育60 min.

 

9.将培养皿中的内容物倒入废容器中,将孵化器中的混合物移除。用300 ul工作水洗缓冲液冲洗微滴水井5次。把井打在吸水性纸或p上 锥度毛巾,以消除所有残余水滴。

 

10.在每口井中分配100mL TMB溶液。

 

11.室温(18-25°C)孵育20分钟.

 

12.通过在每口井中加入100mL的停止溶液来停止反应。

 

13.轻轻搅拌30秒。重要的是要确保所有的蓝色*变成黄色。

 

14. 在450 nm处读取吸光度,15分钟内使用微滴度良好的阅读器。

统计

 

1.计算每组参考标准、对照和样品的平均吸光度值(OD 450)。

 

2.通过绘制每个参考标准的平均吸光度(以纳克/毫升为单位)绘制在图表纸上,在垂直(Y)轴上绘制吸光度,并绘制标准曲线。 水平(X)轴的接触。

 

3.用每个样品的平均吸光度值,从标准曲线上测定相应的Pd-L1浓度(ng/mL)。取决于经验和/或Comput的可用性 可以采用其他的数据缩减方法。

 

4.得到的样品值应乘以稀释倍数为4,才能得到Pd-L1的结果纳克/毫升。

 

标准曲线实例

 

一个典型的标准运行结果,吸光度读数在450 nm处显示在Y轴上,而pd-L1浓度显示在X轴上。注:本标准曲线为图示目的。 仅用于计算未知数,不应用于计算未知数。每个实验室必须在每个实验中生成自己的数据和标准曲线。

 

工作特性

 

用2SD法测定的Pd-L1酶联免疫吸附试验的低检出浓度为0.02ng/ml,低检出浓度为0.02ng/ml。

 

精度a.在一次测定中,通过对三种不同样品的重复测定,确定了内测精密度.批内可变性如下所示:

 

b.在一系列单独校准的测试中,通过对三个不同样本的重复测量,确定了运行间精密度。批间变异显示b。 below在下面,到下面

 

  • 回收率和线性研究。回收样品加入已知的Pd-L1水平,并一式两份进行测定。平均回收率为90%。

 

 

 

 

b. 对三个样品进行连续稀释,以确定线性度。平均回收率为110.3%。

 

 

参考

1.赫布斯特,罗伊S.,等人。肿瘤患者对抗PD-L1抗体MPDL3280A的反应预测相关。“自然”515.7528(2014年):563。

 

2.帕特尔,桑迪普·普拉文和拉泽尔·库兹洛克。pd-L1的表达是肿瘤免疫治疗中的一个预测生物标志物。分子癌症治疗学14.4(2015):847-856。

 

3.书名/作者责任者:by L.靶向PD-1/B7-H1(PD-L1)通路,激活抗肿瘤免疫。免疫学新意见24.2(2012年):207-212。

 

4.布兰克克里斯汀和安德烈亚斯·马肯森。PD-L1/PD-1通路对T细胞衰竭的贡献:慢性感染和肿瘤逃避的新研究进展。癌症免疫学 治疗,疗法,疗效 56.

 

5(2007):739-745。5.Barber,Daniel L.,等。慢性病毒感染时衰竭CD8 T细胞的功能恢复“自然”439.7077(2006年):682。

 

6.Teng,Michele WL,等。根据T细胞浸润和pd-L1分类癌症。癌症研究75.11(2015):2139-2145。

 

 

 

biocheck 代理  biocheck全国代理  biocheck华南代理  biocheck华中代理 

biocheck北京代理  biocheck 上海代理   biocheck浙江代理   biocheck四川代理

FaSSIF缓冲液浓缩液说明书

 

biorelevant FaSSIF缓冲液浓缩液说明书

 
 
  • 与FaSSIF / FeSSIF / FaSSGF粉末一起使用可在数秒内制成FaSSIF
  • 每次都具有高度可重复的结果
  •  
 

 

 

Biorelevant很高兴推出我们的新型FaSSIF缓冲液浓缩液,使您的生物相关培养基制备更加快捷,轻松和一致。每个瓶子多可装6升FaSSIF缓冲液。只需将浓缩物稀释至所需量的缓冲液,然后与FaSSIF / FeSSIF / FaSSGF粉末(另售)结合使用,每次即可获得出色的效果。

*节省时间*

在不到5分钟的时间内,制作几乎所需数量的FaSSIF:

 

*可重复的结果*

每瓶都带有分析证书,以保证质量。该图显示了用缓冲液浓缩液产生的FaSSIF的可重现pH测量值:

  • 批次1018A: pH平均值6.48,标准偏差0.01,测量8个样品
  • 批次0219A: pH平均值6.49,标准偏差0.02,测量9个样品

*控制*

方便的包装使您可以控制介质的准备工作。无论准备小批量还是大批量,都可以轻松实现,并且浪费少。

 

用缓冲液浓缩液制成1升FaSSIF

设备

  • 校准天平
  • 适合的容器
  • 搅拌板和PTFE磁体
  • 称重船

方法

  • 称量41.65g(或35.00mL)缓冲液浓缩液到合适的容器中
  • 称取961.1g净化水到容器中以产生缓冲液
  • 在称量舟中称量2.240g FaSSIF / FeSSIF / FaSSGF粉末,然后添加到容器中。用缓冲液冲洗称量舟,以确保所有粉末都已转移
  • 将容器放在带有PTFE磁体的搅拌器板上。搅拌直至溶解
  • 静置2小时。FaSSIF培养基会变成微乳白色,现在可以使用了

用法

  • 在48小时内使用FaSSIF

 

BioMedica Diagnostics 238L

 

BioMedica Diagnostics是一家自豪的加拿大公司,专注于为人类和动物健康领域提供定制的经济实惠的诊断解决方案。

BioMedica Diagnostics 238L 说明书

SAFETY DATA SHEET

SECTION 1: Identification of the substance/mixture and of the company/undertaking

1.1. Product identifier

 

Trade name or designation of the mixture

Registration number Synonyms

Product code Issue date Version number

SPECTROZYME® TH 50 umole

 

None.     

238L

01-December-2017

02

 

Revision date 11-July-2017

Supersedes date 14-July-2015

1.2. Relevant identified uses of the substance or mixture and uses advised against

 

Identified uses

Uses advised against

Research use only.

Use in accordance with supplier's recommendations.

SECTION 2: Hazards identification

2.1. Classification of the substance or mixture

The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

Classification according to Regulation (EC) 272/2008 as amended

Health hazards

 

Skin corrosion/irritation

Serious eye damage/eye irritation

 

Specific target organ toxicity – single exposure

Category 2

Category 2

 

Category 3 respiratory tract irritation

H315 – Causes skin irritation.

H319 – Causes serious eye irritation.

H335 – May cause respiratory irritation.

 

Hazard summary Irritating to eyes, respiratory system and skin.

2.2. Label elements

Label according to Regulation (EC) 272/2008 as amended

Contains: H-D-cyclohexylalanyl-alanyl-arginine-para-nitroanilide diacetate saltt

Hazard pictograms

 

 

 

Signal word Warning

 

Hazard statements

H315 Causes skin irritation.

H319 Causes serious eye irritation.

H335 May cause respiratory irritation.

 

P261 Avoid breathing dust.

P264 Wash thoroughly after handling.

P271 Use only outdoors or in a well-ventilated area.

P280 Wear protective gloves.

P280 Wear eye/face protection.

Response

P302 + P352 IF ON SKIN: Wash with plenty of water.

P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

P312 Call a POISON CENTER/doctor if you feel unwell. P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention.

P362 + P364 Take off contaminated clothing and wash it before reuse.

Storage

P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental label information None.

2.3. Other hazards Not a PBT or vPvB substance or mixture.

SECTION 3: Composition/information on ingredients

 

Chemical name

% CAS-No / EC

No

REACH Registration No

INDEX No

Notes

 

 

 

H-D-cyclohexylalanyl-alanyl-arginine- para-nitroanilide diacetate saltt

45 – 65

None

 

Classification: Skin Irrit. 2;H315, Eye Irrit. 2;H319, STOT SE 3;H335

 

 

Glycine

 

Classification:

20 – 40

56-40-6

200-272-2

 

Composition comments

All concentrations are in percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume. The full text for all H-statements is displayed in section 16.

 

SECTION 4: First aid measures

 

General information

Ensure that medical personnel are aware of the material(s) involved, and take precautions to protect themselves. If you feel unwell, seek medical advice (show the label where possible).

 

4.1. Description of first aid measures

 

Inhalation Skin contact Eye contact

 

Ingestion

4.2. Most important symptoms and effects, both acute and delayed

4.3. Indication of any immediate medical attention and special treatment needed

Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or doctor/physician if you feel unwell.

Remove contaminated clothing. Wash with plenty of soap and water. If skin irritation occurs: Get medical advice/attention. Wash contaminated clothing before reuse.

Do not rub eyes. Immediay flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persists.

Rinse mouth. Get medical attention if symptoms occur.

May cause redness and pain. Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting.

 

Provide general supportive measures and treat symptomatically.

 

SECTION 5: Firefighting measures

 

General fire hazards

5.1. Extinguishing media Suitable extinguishing media

Unsuitable extinguishing media

5.2. Special hazards arising from the substance or mixture

5.3. Advice for firefighters Special protective equipment for firefighters

Special fire fighting procedures

No unusual fire or explosion hazards noted. Will burn if involved in a fire.

 

Water fog. Foam. Dry chemical powder. Carbon dioxide (CO2). Do not use water jet as an extinguisher, as this will spread the fire. During fire, gases hazardous to health may be formed.

 

Self-contained breathing apparatus and full protective clothing must be worn in case of fire. Use standard firefighting procedures and consider the hazards of other involved materials.

 

SECTION 6: Accidental release measures

6.1. Personal precautions, protective equipment and emergency procedures

 

For non-emergency personnel

 

 

For emergency responders

 

6.2. Environmental precautions

6.3. Methods and material for containment and cleaning up

 

 

 

 

 

6.4. Reference to other sections

Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Wear appropriate protective equipment and clothing during clean-up. Avoid inhalation of dust. Ensure adequate ventilation. Local authorities should be advised if significant spillages cannot be contained.

Keep unnecessary personnel away. Use personal protection recommended in section 8 of the SDS.

Avoid discharge into drains, water courses or onto the ground.

Avoid dispersal of dust in the air (i.e., clearing dust surfaces with compressed air). Collect dust using a vacuum cleaner equipped with HEPA filter. Stop the flow of material, if this is without risk.

 

Large Spills: Wet down with water and dike for later disposal. Shovel the material into waste container. Following product recovery, flush area with water.

 

Small Spills: Sweep up or vacuum up spillage and collect in suitable container for disposal. Clean surface thoroughly to remove residual contamination.

For personal protection, see section 8. For waste disposal, see section 13 of the SDS.

 

SECTION 7: Handling and storage

 

7.1. Precautions for safe handling

 

 

7.2. Conditions for safe storage, including any incompatibilities

7.3. Specific end use(s)

Minimise dust generation and accumulation. Provide appropriate exhaust ventilation at places where dust is formed. Avoid breathing dust. Avoid contact with eyes, skin, and clothing. Avoid prolonged exposure. Wear appropriate personal protective equipment. Observe good industrial hygiene practices.

Store locked up. Store in original tightly closed container. Store in a well-ventilated place. Store away from incompatible materials (see section 10 of the SDS).

 

Research use only.

 

SECTION 8: Exposure controls/personal protection

8.1. Control parameters

 

Occupational exposure limits Biological limit values

Recommended monitoring procedures

No exposure limits noted for ingredient(s).

No biological exposure limits noted for the ingredient(s). Follow standard monitoring procedures.

 

Derived no-effect level (DNEL) Not available.

 

Predicted no effect concentrations (PNECs)

8.2. Exposure controls

Not available.

 

Appropriate engineering controls

Good general ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. If engineering measures are not sufficient to maintain concentrations of dust particulates below the OEL (occupational exposure limit), suitable respiratory protection must be worn. If material is ground, cut, or used in any operation which may generate dusts, use appropriate local exhaust ventilation to keep exposures below the recommended exposure limits. Eye wash facilities and emergency shower must be available when handling this product.

 

Individual protection measures, such as personal protective equipment

 

General information

 

 

Eye/face protection Skin protection

– Hand protection

 

– Other

Respiratory protection

 

Thermal hazards Hygiene measures

 

Environmental exposure controls

Use personal protective equipment as required. Personal protection equipment should be chosen according to the CEN standards and in discussion with the supplier of the personal protective equipment.

Wear safety goggles and a face shield.

 

Wear appropriate chemical resistant gloves. Suitable gloves can be recommended by the glove supplier.

Wear appropriate chemical resistant clothing.

In case of inadequate ventilation or risk of inhalation of dust or fumes, use suitable respiratory equipment.

Wear appropriate thermal protective clothing, when necessary.

Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment to remove contaminants.

Environmental manager must be informed of all major releases.

 

SECTION 9: Physical and chemical properties

9.1. Information on basic physical and chemical properties Appearance

 

Physical state Form

Colour Odour

Solid.

White powder.

White.

Not available.

 

Odour threshold Not available.

pH Not available.

Melting point/freezing point Not available.

 

Initial boiling point and boiling range

Not available.

 

Flash point Not available.

Evaporation rate Not available.

Flammability (solid, gas) Not available.

Upper/lower flammability or explosive limits

 

Flammability limit – lower (%)

Flammability limit – upper (%)

Not available.

 

Not available.

 

Vapour pressure Not available.

Vapour density Not available.

Relative density Not available.

Solubility(ies) Soluble in water.

 

Partition coefficient (n-octanol/water)

Not available.

 

Auto-ignition temperature Not available. Decomposition temperature Not available. Viscosity Not available.

 

Explosive properties Oxidizing properties

9.2. Other information

Not available.

Not available.

No relevant additional information available.

 

SECTION 10: Stability and reactivity

 

10.1. Reactivity

10.2. Chemical stability

10.3. Possibility of hazardous reactions

10.4. Conditions to avoid

10.5. Incompatible materials

10.6. Hazardous decomposition products

The product is stable and non-reactive under normal conditions of use, storage and transport. Material is stable under normal conditions.

Hazardous polymerisation does not occur.

 

Contact with incompatible materials. Strong oxidising agents. Strong acids. Carbon monoxide. Carbon dioxide.

 

SECTION 11: Toxicological information

General information Occupational exposure to the substance or mixture may cause adverse effects.

Information on likely routes of exposure

Inhalation Dust may irritate respiratory system. Prolonged inhalation may be harmful.

Skin contact Causes skin irritation.

Eye contact Causes serious eye irritation.

Ingestion May cause discomfort if swallowed.

Symptoms Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting. May cause redness and pain.

11.1. Information on toxicological effects

Acute toxicity May cause discomfort if swallowed.

 

Skin corrosion/irritation

Serious eye damage/eye irritation

Causes skin irritation. Causes serious eye irritation.

 

Respiratory sensitisation Not a respiratory sensitiser.

 

Skin sensitisation Germ cell mutagenicity

Not a skin sensitiser.

No data available to indicate product or any components present at greater than 0.1% are mutagenic or genotoxic.

 

Carcinogenicity Not classifiable as to carcinogenicity to humans.

 

Reproductive toxicity

Specific target organ toxicity – single exposure

Specific target organ toxicity – repeated exposure

This product is not expected to cause reproductive or developmental effects. May cause respiratory irritation.

 

Not classified.

 

Aspiration hazard Not classified.

 

Mixture versus substance information

Not available.

 

Other information No other specific acute or chronic health impact noted.

 

SECTION 12: Ecological information

12.1. Toxicity The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.

 

12.2. Persistence and degradability

12.3. Bioaccumulative potential

Partition coefficient

n-octanol/water (log Kow)

No data is available on the degradability of this product.

 

 

Not available.

 

Bioconcentration factor (BCF) Not available.

 

12.4. Mobility in soil

12.5. Results of PBT and vPvB assessment

No data available.

Not a PBT or vPvB substance or mixture.

 

12.6. Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation potential, endocrine disruption, global warming potential) are expected from this component.

 

SECTION 13: Disposal considerations

13.1. Waste treatment methods

 

Residual waste

 

 

Contaminated packaging

 

 

EU waste code

 

Disposal methods/information

Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a safe manner (see: Disposal instructions).

Empty containers should be taken to an approved waste handling site for recycling or disposal. Since emptied containers may retain product residue, follow label warnings even after container is emptied.

The Waste code should be assigned in discussion between the user, the producer and the waste disposal company.

Collect and reclaim or dispose in sealed containers at licensed waste disposal site. Dispose of contents/container in accordance with local/regional/national/international regulations.

 

SECTION 14: Transport information

ADR

Not regulated as dangerous goods.

RID

Not regulated as dangerous goods.

ADN

Not regulated as dangerous goods.

IATA

Not regulated as dangerous goods.

IMDG

Not regulated as dangerous goods.

 

14.7. Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code

Not applicable.

 

SECTION 15: Regulatory information

15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture EU regulations

Regulation (EC) 005/2009 on substances that deplete the ozone layer, Annex I and II, as amended

Not listed.

Regulation (EC) No 850/2004 On persistent organic pollutants, Annex I as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 1 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 2 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 3 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex V as amended

Not listed.

Regulation (EC) No 166/2006 Annex II Pollutant Release and Transfer Registry, as amended

Not listed.

Regulation (EC) 907/2006, REACH Article 59(10) Candidate List as currently published by ECHA

Not listed.

Authorisations

Regulation (EC) 907/2006, REACH Annex XIV Substances subject to authorization, as amended

Not listed.

Restrictions on use

Regulation (EC) No1907/2006, REACH Annex XVII Substances subject to restriction on marketing and use as amended

Not listed.

Directive 2004/37/EC: on the protection of workers from the risks related to exposure to carcinogens and mutagens at work, as amended

Not listed.

Directive 92/85/EEC: on the safety and health of pregnant workers and workers who have recently given birth or are breastfeeding, as amended

Not listed.

Other EU regulations

Directive 2012/18/EU on major accident hazards involving dangerous substances

Not listed.

 

Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

Not listed.

Directive 94/33/EC on the protection of young people at work

Not listed.

 

Other regulations

 

 

 

 

National regulations

15.2. Chemical safety assessment

The product is classified and labelled in accordance with Regulation (EC) 1272/2008 (CLP Regulation) as amended and respective national laws implementing EC directives. This Safety Data Sheet complies with the requirements of Regulation (EC) 907/2006.

In the European Union this product is regulated under the In Vitro Diagnostic Medical Devices Directive (98/79/EC).

Follow national regulation for work with chemical agents. No Chemical Safety Assessment has been carried out.

 

SECTION 16: Other information

List of abbreviations

 

 

 

References

Information on evaluation method leading to the classification of mixture

Full text of any H-statements not written out in full under Sections 2 to 15

 

 

Training information Disclaimer

DNEL: Derived No-Effect Level.

PNEC: Predicted No-Effect Concentration.

IARC Monographs. Overall Evaluation of Carcinogenicity

The classification for health and environmental hazards is derived by a combination of calculation methods and test data, if available.

 

 

 

H315 Causes skin irritation.

H319 Causes serious eye irritation. H335 May cause respiratory irritation.

Follow training instructions when handling this material.

The information above is provided in good faith. It is believed to be accurate and represents the best information currently available to us. HOWEVER, WE MAKE NO WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER TYPE, EXPRESSED OR IMPLIED, WITH RESPECT TO PRODUCTS DESCRIBED OR DATA OR INFORMATION PROVIDED, AND WE ASSUME NO LIABILITY RESULTING FROM THE USE OF

SUCH PRODUCTS, DATA OR INFORMATION. Users should make their own investigations to determine the suitability of the information for their particular purposes, and the user assumes all risk arising from their use of the material. The user is required to comply with all laws and regulations relating to the purchase, use, storage and disposal of the material, and must be familiar with and follow generally accepted safe handling procedures. In no event shall BioMedica Diagnostics be liable for any claims, losses, or damages of any individual or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if BioMedica Diagnostics has been advised of the possibility of such damages.

 

 

上海金畔生物科技有限公司是实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争力的价格优势,绝大部分价格有优势。

5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

纤维素酶R-10 L0012 YaKult.Co L0012

产品型号

品       牌

产品简介

本公司各种实验室生化试剂大量备现货,欢迎广大新老客户订购

详情介绍

Acetyl Coenzyme A 乙酰辅酶 A Roche分装 5mg 
Acetyl Coenzyme A 乙酰辅酶 A SigmaA-2056 2mg 
a-Amylase a-* SigmaA4551 100mg 
amylase * 日本 500g 
Catalase过氧化氢酶(牛肝) SigmaC9322 1g 
Collagenase胶原酶I(分装) GIBCO17100-017 100mg 
Collagenase胶原酶I(分装) GIBCO17100-017 100mgX10 
Collagenase胶原酶I 原装 GIBCO17100-017 1g 
Collagenase胶原酶II(分装) GIBCO17101-015 100mg 
Collagenase胶原酶II(分装) GIBCO17101-015 100mgX10 
Collagenase胶原酶II(原装) GIBCO17101-015 1g 
Collagenase胶原酶III GIBCO17102-013 100mg 
Collagenase胶原酶IV(分装) GIBCO17104-019 100mg 
Collagenase胶原酶IV(分装) GIBCO17104-019 100mgX10 
Collagenase胶原酶IV(原装) GIBCO17104-019 1g 
Collagenase胶原酶V SigmaC-9263 25mg 
Collagenase胶原酶IA SigmaC-9891 25mg 
Driselase 崩溃酶 SigmaD9515 500mg 
溶壁酶Lyticase from Arthrobacter luteus  USA   >2400u/mg 1g 
Aprotinin蛋白酶抑制剂 Amresco 2mg 
Aprotinin蛋白酶抑制剂 Roche981532 2mg 
ProteinaseK蛋白酶K Merck原装 100mg 
ProteinaseK蛋白酶K Merck原装 100mgX10 
Pronase E * E Roche459643 250mg 
Pronase E * E Roche459643 1g 
Leupeptin亮抑酶肽 Amresco 2mg 
Leupeptin亮抑酶肽 Amresco 5mg 

美国Millipore石英纤维滤纸

产品型号

品       牌

产品简介

本公司各种过滤层析类耗材大量备现货,欢迎广大新老客户订购

详情介绍

产品名称:Millipore含粘合剂玻璃纤维滤AP15

产品参数:Millipore含粘合剂玻璃纤维滤纸具有较高的湿强度,负载力强。适用于定性分析或预过滤,也可用于水溶液的澄清。可以EtO灭菌、高压灭菌或者辐照灭菌。

产品编号    产品描述 产品包装 
AP1502500 直径:25mm 100片/盒        
AP1504200 直径:42mm 100片/盒      
AP1504700 直径:47mm 100片/盒        
AP1507500 直径:75mm 100片/盒   
AP1509000 直径:90mm 100片/盒     
AP1512450 直径:124mm 50片/盒     
AP1514250 直径:124mm 50片/盒     
AP1525725 直径:257mm 25片/盒      
AP1529325 直径:293mm 25片/盒

 

产品名称:Millipore含粘合剂玻璃纤维滤AP20

产品参数:Millipore含粘合剂玻璃纤维滤纸具有较高的湿强度,负载力强。适用于定性分析或预过滤,也可用于水溶液的澄清。可以EtO灭菌、高压灭菌或者辐照灭菌。

产品编号  产品描述    产品包装  
AP2002500 直径:25mm 100片/盒   
AP2004200 直径:42mm 100片/盒      
AP2004700 直径:47mm 100片/盒      
AP2007500 直径:75mm 100片/盒    
AP2009000 直径:90mm 100片/盒 
AP2012450 直径:124mm 50片/盒   
AP2014250 直径:124mm 50片/盒    
AP2025725 直径:257mm 25片/盒    
AP2029325 直径:293mm 25片/盒

 

产品名称:Millipore含粘合剂玻璃纤维滤AP25

产品参数:Millipore含粘合剂玻璃纤维滤纸具有较高的湿强度,负载力强。适用于定性分析或预过滤,也可用于水溶液的澄清。可以EtO灭菌、高压灭菌或者辐照灭菌。

 

产品编号  产品描述    产品包装
AP2502500 直径:25mm 100片/盒        
AP2504200 直径:42mm 100片/盒      
AP2504700 直径:47mm 100片/盒     
AP2507500 直径:75mm 100片/盒        
AP2509000 直径:90mm 100片/盒      
AP2512450 直径:124mm 50片/盒      
AP2514250 直径:124mm 50片/盒      
AP2525725 直径:257mm 25片/盒       
AP2529325 直径:293mm 25片/盒

 

产品名称:石英纤维滤纸

产品参数:高纯石英纤维滤纸,不含玻璃纤维和粘合剂。不会和酸性气体反应而影响分析。适用于重金属污染分析和微粒分析,如USEPA PM10环境空气采样机收集颗粒物。可以EtO灭菌、高压灭菌或辐照灭菌。厚度430±70μm,水流速1.6ml/min/cm2。

 

产品编号  产品描述           产品包装
AQFA03200 直径:32mm         100片/盒      
AQFA03700 直径:37mm         100片/盒    
AQFA04700 直径:47mm         100片/盒     
AQFA05500 直径:55mm         100片/盒      
AQFA09050 直径:90mm         50片/盒    
AQFA11050 直径:110mm        50片/盒     
AQFA11850 直径:118mm        50片/盒  
AQFA8X105 直径:8×10in.mm   50片/盒

 

Stbl3菌株说明书

 Stbl3菌株说明书

型号 载体名称 出品公司 载体用途
VDI0385 Stbl3 Invitrogen 配套大肠杆菌

 

载体描述: 

The One Shot® Stbl3™ E. coli strain is designed especially for cloning direct repeats found in lentiviral expression vectors. Unlike *0 E. coli, these cells reduce the frequency of homologous recombination of long terminal repeats (LTRs) found in ViraPower™ Lentiviral Expression Vector and other retroviral vectors. The DNA yield from Stbl3™ cells is often >10-fold higher than alternative strains such as *0.

 

Components Supplied Amount 

Stbl3™ Cells                                  21 x 50 µl 

pUC19 Control DNA (10 pg/µl)       50 µl 

S.O.C. Medium                                6 ml

 

 

pWPXL载体说明书


 pWPXL载体

型号 载体名称 出品公司 载体用途
VMA0376 pWPXL Addgene 慢病毒载体

 

载体序列

1       ttggaagggc      taattcactc      ccaaagaaga      caagatatcc      ttgatctgtg      50
51      gatctaccac      acacaaggct      acttccctga      ttagcagaac      tacacaccag      100
101     ggccaggggt      cagatatcca      ctgacctttg      gatggtgcta      caagctagta      150
151     ccagttgagc      cagataaggt      agaagaggcc      aataaaggag      agaacaccag      200
201     cttgttacac      cctgtgagcc      tgcatgggat      ggatgacccg      gagagagaag      250
251     tgttagagtg      gaggtttgac      agccgcctag      catttcatca      cgtggcccga      300
301     gagctgcatc      cggagtactt      caagaactgc      tgatatcgag      cttgctacaa      350
351     gggactttcc      gctggggact      ttccagggag      gcgtggcctg      ggcgggactg      400
401     gggagtggcg      agccctcaga      tcctgcatat      aagcagctgc      tttttgcctg      450
451     tactgggtct      ctctggttag      accagatctg      agcctgggag      ctctctggct      500
501     aactagggaa      cccactgctt      aagcctcaat      aaagcttgcc      ttgagtgctt      550
551     caagtagtgt      gtgcccgtct      gttgtgtgac      tctggtaact      agagatccct      600
601     cagacccttt      tagtcagtgt      ggaaaatctc      tagcagtggc      gcccgaacag      650
651     ggacttgaaa      gcgaaaggga      aaccagagga      gctctctcga      cgcaggactc      700
质粒图谱: 

 

纤维素酶R-10 L0012原装YaKult.Co L0012

产品型号

品       牌

产品简介

本公司各种实验室生化试剂大量备现货,欢迎广大新老客户订购

详情介绍

以下是部分现货的zui小包装库存 咨询 021 51619380  价优

Acetyl Coenzyme A 乙酰辅酶 A Roche分装 5mg 
Acetyl Coenzyme A 乙酰辅酶 A SigmaA-2056 2mg 
a-Amylase a-* SigmaA4551 100mg 
amylase * 日本 500g 
Catalase过氧化氢酶(牛肝) SigmaC9322 1g 
Collagenase胶原酶I(分装) GIBCO17100-017 100mg 
Collagenase胶原酶I(分装) GIBCO17100-017 100mgX10 
Collagenase胶原酶I 原装 GIBCO17100-017 1g 
Collagenase胶原酶II(分装) GIBCO17101-015 100mg 
Collagenase胶原酶II(分装) GIBCO17101-015 100mgX10 
Collagenase胶原酶II(原装) GIBCO17101-015 1g 
Collagenase胶原酶III GIBCO17102-013 100mg 
Collagenase胶原酶IV(分装) GIBCO17104-019 100mg 
Collagenase胶原酶IV(分装) GIBCO17104-019 100mgX10 
Collagenase胶原酶IV(原装) GIBCO17104-019 1g 
Collagenase胶原酶V SigmaC-9263 25mg 
Collagenase胶原酶IA SigmaC-9891 25mg 
Driselase 崩溃酶 SigmaD9515 500mg 
溶壁酶Lyticase from Arthrobacter luteus  USA   >2400u/mg 1g 
Aprotinin蛋白酶抑制剂 Amresco 2mg 
Aprotinin蛋白酶抑制剂 Roche981532 2mg 
ProteinaseK蛋白酶K Merck原装 100mg 
ProteinaseK蛋白酶K Merck原装 100mgX10 
Pronase E * E Roche459643 250mg 
Pronase E * E Roche459643 1g 
Leupeptin亮抑酶肽 Amresco 2mg 
Leupeptin亮抑酶肽 Amresco 5mg 
* SigmaL6875 1g 
* Amresco 1g 
* Amresco 5g 
MacerozymeR-10离析酶R-10 YaKult.CoL0021分装 1g 
MacerozymeR-10离析酶R-10 YaKult.CoL0021分装 10g 
MacerozymeR-10离析酶R-10 YaKult.CoL0021原装 100g 
Pepsin1:3000*1:3000 Amresco 25g 
Pepsin1:3000*1:3000 Amresco 250g 
Pepsin1:10000*1:10000 SigmaP7000 5g 
Pepsin1:10000*1:10000 SigmaP7000 25g 
Pepsin1:60000*1:60000 SigmaP7012 250mg 
Pepstatin A*抑制剂 AmrescoJ583 5mg 
Pepstatin A*抑制剂 Sigma P-4265 5mg 
DNaseI (脱氧核糖核酸酶I) 国产 25mg 
DNaseI (脱氧核糖核酸酶I) Roche104159 25mg 
Hyaluronidase透明质酸酶 SigmaH3506 100mg 
HRP辣根过氧化物酶 Roche121606 10mg 
HRP辣根过氧化物酶 国产 100mg 
L-乳酸脱氢酶 SigmaL-2500 5000u 
NAD98%辅酶I Roche004626 500mg 
NAD98%辅酶I Roche004626 1g 
NADH还原型辅酶I Roche004642 250mg 
NADH还原型辅酶I           Roche004642 1g 
NADP氧化型辅酶II Roche004669 100mg 
NADP氧化型辅酶II Roche004669 500mg 
NADP氧化型辅酶II Roche004669 1g 
NADPH还原型辅酶II四钠 Roche041939 25mg 
NADPH还原型辅酶II四钠 Roche041939 100mg 
Papain木瓜蛋白酶 SigmaP-3250 10g 
果胶酶 Pectolyase USA  5g 
PectolyaseY-23果胶酶Y-23 YaKult.Co分装 100mg 
PectolyaseY-23果胶酶Y-23 YaKult.Co分装 1g 
PectolyaseY-23果胶酶Y-23 YaKult.Co原装 10g原装 
纤维素酶 cellulase USA  10g 
纤维素酶R-10  L0012分装 YaKult.Co L0012 分装 1g 
纤维素酶R-10  L0012分装 YaKult.Co L0012 分装 10g 
纤维素酶R-10  L0012原装 YaKult.Co L0012 原装 100g原装 
Rnase A (核糖核酸酶A) Sigma 25mg 
Rnase A (核糖核酸酶A) Amresco 25mg 
Rnase A (核糖核酸酶A) Amresco 100mg 
超氧化物歧化酶(SOD) SigmaS2515 3000u 
RNase核糖核酸酶 国产 100mg 
RNA酶抑制剂 Rnase Inhibitor  Promega分装 1000u 
3-磷酸甘油醛脱氢酶(GAPDH) Roche 500u 
 3-磷酸甘油酸磷酸激酶3-Phosphoglyceric Phosphokinase  CAS:9001-83-6 SigmaP7634 500u 
甘油-3-磷酸氧化酶 USA 500u 
葡萄糖氧化酶 SigmaG7141 10000u 
B-葡萄糖苷酶 SigmaG4511 10u 
B-D-半乳糖苷酶 SigmaG2513 500u 
葡萄糖-6-磷酸脱氢酶 SigmaG7750 100u 
Hexokinase已糖激酶 SigmaH5625 500u 
乙醇脱氢酶 SigmaA7011 7.5ku 
苹果酸脱氢酶 Sigma 5ku 
磷酸葡萄糖异构酶(PGL) SigmaP2338 500u 
磷酸葡萄糖变位酶(PGM) Sigma 500u 
丙酮酸激酶(PK) SigmaP9136  500U分装 
丙酮酸氧化酶 Pyruvate Oxidase bacterial  USA 100u 
*氧化酶 BBL 500u 
*氨基转移酶(转氨酶)(ALT)Alanine aminotransferase(ALT)  USA 100u 
脂蛋白脂酶(LPL) lipoprotein Lipase LPL BBL 100u 
尿酸酶(*)Uricase,Urate Oxidase  USA 25u 
*(蚯蚓酶)(Lumbrokinase BBL 1000u 
* Sigma 1g 
磷酸肌酸激酶 SigmaC7886 500u 
甘油激酶 glycerokinase USA 100u 
PEP(磷酸烯醇式丙酮酸) Sigma P3637  100mg 
*脱氢酶 SigmaG3664原装 100UN 
Hemicellulase半纤维素酶 Sigma H2125 0.3-3.0u/mg 150KU 
Lipase 脂肪酶 Sigma L1754 5g 
Phytase 植酸酶 USA 5g 
Urokinase * USA 5ku 
“UREASE 脲酶(尿素酶)
” BBL 1g 
糖化酶Glucoamylase 美国BBL 500mg 
* Coenzyme A (Co A)  SigmaC4282 25mg 
* Coenzyme Q10 USA 1g 
硫胺素焦磷酸(TPP) (羧化辅酶)(辅羧酶) Thiamine pyrophosphate  BBL 1g 
腺苷二磷酸葡萄糖焦磷酸化酶(AGPP)ADP glucose pyrophosphorylase,AGPP  USA 10ug 
木聚糖酶Xylanase USA 1g 
葡聚糖酶 Dextranase USA 1g 
氨基酰化酶 L-Acylase  BBL 1g 
Acidic Protease酸性蛋白酶 USA 100g 
Neutral protease * USA 100g 
Basic protease 碱性蛋白酶 USA 100g 
*1:250 (牛胰) GIBCO 25g 
*1:250 (牛胰) Amresco 25g 
*1:250(牛胰) Amresco 100g 
*1:250(牛胰腺)≥2500u/mg USA 1g 
*/* USA 500mg 
胰高血糖素Glucagon USA 5mg 
*抑制剂 美国   水能溶解 5mg 
*抑制剂 Roche109878  异丙醇溶 100mg 
Thrombin* SigmaT4648 1000u 
Snailase蜗牛酶 国产 1g 
黄嘌呤氧化酶 Sigma 5u 
核酸及其行生物   

advancedbiosystemsinc 1991-07L说明书


 

advancedbiosystemsinc 1991-07L说明书

抗小鼠/兔子2步HRP聚合物检测试剂盒

Anti-Mouse/Rabbit 2-Step HRP Polymer Detection Kit (made in Goat, 125ml)

$ 1,170.00

快速概述

目录编号:1991-07L

单位面积:125ml

 

 

功能:                                                                         下载产品数据表 

放大聚合物检测技术

更高的灵敏度将显着降低一抗的成本

无生物素技术

脆而强烈的染色

超级干净的背景

 

产品信息:  

目录编号

1991-07L(125ml,无色原)

产品描述:

ImmunoHistoProbe Plus抗小鼠/兔子HRP聚合物检测试剂盒(山羊制)

寄主物种:

山羊

特异性

小鼠+兔IgG(H + L)

交叉反应性:

与人血清蛋白的小交叉反应性。

防腐剂

Proclin 300

共轭酶

聚合辣根过氧化物酶

应用:

冷冻和石蜡包埋组织的免疫组织化学。 

 

有可能的使用: 

仅适用于体外实验室。不用于诊断或治疗用途。

 

ImmunoHistoProbe Pluse抗兔/小鼠HRP聚合物检测试剂盒专为人类组织中小鼠和兔一抗的可视化而设计。组织样品可以是石蜡包埋的组织切片,冷冻切片和细胞制剂。它仅供研究使用。 

 

背景介绍:

ImmunoHistoProbe Plus抗小鼠/兔HRP聚合物检测试剂盒利用新的无生物素聚合技术制备超灵敏聚合物过氧化物酶连接的缀合物。它基于使用两步聚合物检测方法的信号放大。通过用于一抗的放大器检测对组织切片上的抗原特异的一抗,然后检测聚合物检测器。然后用合适的底物/色原体强烈可视化抗原位点。与常规标记的链霉抗生物素蛋白 – 生物素或抗生物素蛋白生物素复合物方法相比,它*消除了内源性生物素活性对富含生物素的组织的潜在背景。ImmunoHistoProbe Plus试剂盒使用新的聚合技术,允许大量过氧化物酶与二抗结合。这将显着提高灵敏度。可能需要重新调整一抗的宜稀释度和孵育时间。

 

在染色之前,如果需要,在加热诱导的表位修复或酶预处理后,福尔马林固定的石蜡组织切片应脱石蜡并水合。应阻断内源性过氧化物酶。然后加入一抗,在宜滴定和条件下孵育。在用一抗标记组织或细胞制剂上的抗原后,加入放大器并孵育10-15分钟。然后应用亲和纯化的人血清吸收的聚合物HRP缀合的检测器10-15分钟。聚合物HRP酶将催化底物/ chomogen,3,3'-二氨基联苯胺(DAB)或3-氨基-9-乙基咔唑(AEC)反应,以在抗原位点形成可见棕色(DAB)或红色(AEC)沉积物。然后可以在显微镜下观察抗原。当色彩发展达到令人满意的程度2 O停止反应。染色的载玻片可以用水性封固剂或有机封固剂固定。 

 

试剂提供:

试剂盒中提供的每种试剂的体积如下:  

包含试剂                                                                 

格式

1991-07L

试剂1:小鼠/兔子放大器(准备使用)

浅黄色液体

1x125ml

试剂2:HRP聚合物检测器(即用型)

液体有红色

1x125ml

 

寄主物种 山羊
检测一抗 没有
SKU 1991-07L
尺寸 125毫升
价钱 $ 1,170.00